Home / CAD / ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education

ACTO secures $23.5 million CAD as pandemic tailwinds increase demand for life sciences education

AstraZeneca is one of ACTO’s biggest customers. With a focus on training and data tracking for life sciences salespeople, ACTO has secured $23.5 million CAD ($18 million USD) in Series B, equity …
Read Full Story at source (may require registration)